Jefferies Upgrades Inovio Pharmaceuticals to Buy, Raises Price Target to $3
Benzinga Newsdesk 2 months ago
NewsUpgradesAnalyst RatingsPrice Target
Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.
Jefferies analyst Roger Song upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Hold to Buy and raises the price target from $1.8 to $3.